Zhejiang Realsun ChemicalLtd Third Quarter 2024 Earnings: CN¥0.031 loss per share (vs CN¥0.079 profit in 3Q 2023)
Zhejiang Realsun ChemicalLtd (SZSE:301212) Third Quarter 2024 Results
Key Financial Results
- Revenue: CN¥127.6m (up 10% from 3Q 2023).
- Net loss: CN¥2.92m (down by 134% from CN¥8.48m profit in 3Q 2023).
- CN¥0.031 loss per share (down from CN¥0.079 profit in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Zhejiang Realsun ChemicalLtd shares are down 1.7% from a week ago.
Risk Analysis
We don't want to rain on the parade too much, but we did also find 3 warning signs for Zhejiang Realsun ChemicalLtd (2 don't sit too well with us!) that you need to be mindful of.
Valuation is complex, but we're here to simplify it.
Discover if Zhejiang Realsun ChemicalLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SZSE:301212
Zhejiang Realsun ChemicalLtd
Manufactures pharmaceutical intermediates and other chemical products in China, the United States, Europe, Africa, the Middle East, Southeast Asia, and other regions.
Adequate balance sheet low.